Therapeutic antibodies are a commercially and medically very successful treatment modality. In this section, you will find reports and other services providing you with the most uptodate business and competitive intelligence information on antibodies and antibody technologies. The range of products covers industry data as well as in-depth strategic assessment and analysis of antibody technologies, R&D pipeline, and sales and market data.
2022 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a landscape analysis of technologies, targets, business and financing from an industry perspective
Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing